Equities Analysts Offer Predictions for KYTX Q1 Earnings
Kyverna Therapeutics, Inc. (NASDAQ:KYTX – Free Report) – Research analysts at HC Wainwright cut their Q1 2025 EPS estimates for Kyverna Therapeutics in a note issued to investors on Thursday, April 3rd. HC Wainwright analyst M. Kapoor now forecasts that the company will post earnings of ($0.87) per share for the quarter, down from their […]
